Many analysts are skeptical that a turnaround in Lululemon's U.S. product offerings will be swift enough to warrant conviction on the stock.

Lululemon reported second-quarter earnings Thursday, beating quarterly earnings and revenue estimates but issuing a weak 2025 outlook.

Many analysts are skeptical that a turnaround in Lululemon's U.S. product offerings will be swift enough to warrant conviction on the stock.